Funding

The following organisations have provided funding for the NOD Cataract and Age-Related Macular Degeneration Audits.

The National Cataract Audit is currently funded through participation fees from centres as well as financial contributions from AlconBausch + Lomb and Rayner.

The Age-Related Macular Degeneration (AMD) Audit is currently kindly funded by the Macular SocietyNovartisRoche and Bayer. This project has been supported by a financial grant from Bayer Plc. Bayer Plc has had no involvement whatsoever in the development or implementation of the project.

 

We are grateful for the funding received from Alcon for the National Cataract Audit.
We are grateful for the funding received from Alcon for the National Cataract Audit. 

 

We are grateful for the funding received from Bausch + Lomb for the National Cataract Audit.
We are grateful for the funding received from Bausch + Lomb for the National Cataract Audit. 

 

We are grateful for the funding received from Rayner for the National Cataract Audit.
We are grateful for the funding received from Rayner for the National Cataract Audit.
We are grateful for the funding received from the Macular Society for the National AMD Audit.
We are grateful for the funding received from the Macular Society for the National AMD Audit.

 

We are grateful for the funding received from Novartis for the National AMD Audit.
We are grateful for the funding received from Novartis for the National AMD Audit. 

 

Want more?

If you have any questions about the information available on this site, please email noa.project@rcophth.ac.uk